Literature DB >> 25973221

How to analyze tumor stage data in clinical research.

Zhi-De Hu1, Zhi-Rui Zhou1, Shi Qian1.   

Abstract

Tumor staging serves as an important prognostic factor in cancer patient care. It also plays critical roles in cancer-related clinical research. Aimed to shed lights on how to analyze tumor staging related data and deliver proper interpretation, various statistical methods, from categorical data analysis to modeling techniques, were introduced through the examples. General guidelines were discussed for how to choose proper statistical test with key considerations of research aims, study design, measurement scale of data, proper data summary, type of associations, and underlying assumptions of statistical methods.

Entities:  

Keywords:  Tumor stage; cancer research; clinical interpretation; statistical methods

Year:  2015        PMID: 25973221      PMCID: PMC4419298          DOI: 10.3978/j.issn.2072-1439.2015.04.09

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  4 in total

1.  JGCA (The Japan Gastric Cancer Association). Gastric cancer treatment guidelines.

Authors:  Y Shimada
Journal:  Jpn J Clin Oncol       Date:  2004-01       Impact factor: 3.019

2.  Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium.

Authors:  Sergio Pecorelli
Journal:  Int J Gynaecol Obstet       Date:  2009-05       Impact factor: 3.561

3.  Report of the Committee on Hodgkin's Disease Staging Classification.

Authors:  P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

4.  The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

Authors:  Stephen B Edge; Carolyn C Compton
Journal:  Ann Surg Oncol       Date:  2010-06       Impact factor: 5.344

  4 in total
  4 in total

1.  Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naïve pancreatic cancer patients.

Authors:  Erin E Talbert; Heather L Lewis; Matthew R Farren; Mitchell L Ramsey; Jeffery M Chakedis; Priyani Rajasekera; Ericka Haverick; Angela Sarna; Mark Bloomston; Timothy M Pawlik; Teresa A Zimmers; Gregory B Lesinski; Phil A Hart; Mary E Dillhoff; Carl R Schmidt; Denis C Guttridge
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-01-07       Impact factor: 12.910

2.  Investigation of Cervical Tumor Biopsies for Chromosomal Loss of Heterozygosity (LOH) and Microsatellite Instability (MSI) at the HLA II Locus in HIV-1/HPV Co-infected Women.

Authors:  Ramadhani Chambuso; Evelyn Kaambo; Lynette Denny; Clive M Gray; Anna-Lise Williamson; Monika Migdalska-Sęk; Gloudi Agenbag; George Rebello; Raj Ramesar
Journal:  Front Oncol       Date:  2019-10-15       Impact factor: 6.244

3.  Prognostic Nutritional Index in Hepatocellular Carcinoma Patients With Hepatitis B Following US-Guided Percutaneous Microwave Ablation: A Retrospective Study With 1,047 Patients.

Authors:  Yaxi Wang; Xin Li; Jie Yu; ZhiGang Cheng; Qidi Hou; Ping Liang
Journal:  Front Surg       Date:  2022-06-29

Review 4.  Cell-free DNA in cancer: current insights.

Authors:  Heidi Fettke; Edmond M Kwan; Arun A Azad
Journal:  Cell Oncol (Dordr)       Date:  2018-10-26       Impact factor: 7.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.